Prodesse Inc.
Prodesse Inc. of Waukesha, Wis., and
Invitrogen Corp. of Carlsbad, Calif., have signed a licensing agreement for diagnostic
assays that incorporate the latter company’s Lux technology, reagents used
in gene expression studies, biomarker analysis and functional genomics experiments.
The arrangement will use Prodesse’s distribution capabilities to bring the
technology to new market segments.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024